[go: up one dir, main page]

BR0010618A - Sistema terapêutico transdermal (tts), que contém tolterodina - Google Patents

Sistema terapêutico transdermal (tts), que contém tolterodina

Info

Publication number
BR0010618A
BR0010618A BR0010618-6A BR0010618A BR0010618A BR 0010618 A BR0010618 A BR 0010618A BR 0010618 A BR0010618 A BR 0010618A BR 0010618 A BR0010618 A BR 0010618A
Authority
BR
Brazil
Prior art keywords
tts
therapeutic system
transdermal therapeutic
tolterodine
containing tolterodine
Prior art date
Application number
BR0010618-6A
Other languages
English (en)
Inventor
Christoph Arth
Claus Meese
Dietrich Wilhelm Schacht
Hans-Michael Wolff
Original Assignee
Sanol Arznei Schwarz Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanol Arznei Schwarz Gmbh filed Critical Sanol Arznei Schwarz Gmbh
Publication of BR0010618A publication Critical patent/BR0010618A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Patente de Invenção: "SISTEMA TERAPêUTICO TRANSDERMAL (TTS), QUE CONTéM TOLTERODINA". A invenção refere-se a um sistema terapêutico transdermal (TTS) para a administração transcutânea de tolterodina por vários dias, bem como a um processo para produção do mesmo. O TTS contém uma massa de matriz em forma de camadas, auto-adesiva, que contém um copolímero de (met)acrilato, que contém grupos amónio, pelo menos um emoliente e até 25% em peso de tolterodina.
BR0010618-6A 1999-05-18 2000-05-16 Sistema terapêutico transdermal (tts), que contém tolterodina BR0010618A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19922662A DE19922662C1 (de) 1999-05-18 1999-05-18 Transdermales therapeutisches System (TTS) Tolterodin enthaltend
PCT/EP2000/004360 WO2000069421A2 (de) 1999-05-18 2000-05-16 Transdermales therapeutisches system (tts) tolterodin enthaltend

Publications (1)

Publication Number Publication Date
BR0010618A true BR0010618A (pt) 2002-02-19

Family

ID=7908327

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0010618-6A BR0010618A (pt) 1999-05-18 2000-05-16 Sistema terapêutico transdermal (tts), que contém tolterodina

Country Status (19)

Country Link
US (1) US6783769B1 (pt)
EP (1) EP1178782B1 (pt)
JP (1) JP2002544222A (pt)
CN (1) CN1356894A (pt)
AT (1) ATE335469T1 (pt)
AU (1) AU772648B2 (pt)
BR (1) BR0010618A (pt)
CA (1) CA2373629A1 (pt)
DE (2) DE19922662C1 (pt)
DK (1) DK1178782T3 (pt)
ES (1) ES2270832T3 (pt)
HK (1) HK1047703A1 (pt)
MX (1) MXPA01011536A (pt)
NO (1) NO20015614L (pt)
PL (1) PL352057A1 (pt)
PT (1) PT1178782E (pt)
RU (1) RU2251413C2 (pt)
WO (1) WO2000069421A2 (pt)
ZA (1) ZA200108147B (pt)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0957073A1 (en) * 1998-05-12 1999-11-17 Schwarz Pharma Ag Novel derivatives of 3,3-diphenylpropylamines
DE19932651A1 (de) * 1999-07-13 2001-01-18 Hexal Ag Transdermales therapeutisches System zur Anwendung von Tolterodin
USRE44145E1 (en) 2000-07-07 2013-04-09 A.V. Topchiev Institute Of Petrochemical Synthesis Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
AU2002316053A1 (en) 2001-05-01 2002-11-11 A.V. Topchiev Institute Of Petrochemical Synthesis Two-phase, water-absorbent bioadhesive composition
US20050113510A1 (en) 2001-05-01 2005-05-26 Feldstein Mikhail M. Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components
US8541021B2 (en) 2001-05-01 2013-09-24 A.V. Topchiev Institute Of Petrochemical Synthesis Hydrogel compositions demonstrating phase separation on contact with aqueous media
US8206738B2 (en) 2001-05-01 2012-06-26 Corium International, Inc. Hydrogel compositions with an erodible backing member
US8840918B2 (en) 2001-05-01 2014-09-23 A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences Hydrogel compositions for tooth whitening
US20050215727A1 (en) 2001-05-01 2005-09-29 Corium Water-absorbent adhesive compositions and associated methods of manufacture and use
RU2276998C2 (ru) 2001-05-01 2006-05-27 Институт Нефтехимического Синтеза Имени А.В. Топчиева Российской Академии Наук Гидрогелевые композиции
DE10315917A1 (de) * 2003-04-08 2004-11-18 Schwarz Pharma Ag Hochreine Basen von 3,3-Diphenylpropylaminmonoestern
EP1713450B1 (en) 2004-01-30 2021-10-06 Corium, Inc. Rapidly dissolving film for delivery of an active agent
MX2007001512A (es) 2004-08-05 2007-04-20 Corium Int Inc Composicion adhesiva.
CN1795845B (zh) * 2004-12-23 2010-10-13 李又欣 作为毒蕈碱受体拮抗剂的3，3-二苯基丙胺衍生物注射用缓释微球制剂
WO2006074479A1 (en) * 2005-01-10 2006-07-13 Teva Pharmaceutical Industries, Ltd. Process for preparing tolterodine tartrate
RU2411045C2 (ru) * 2005-01-27 2011-02-10 Институт Нефтехимического Синтеза Имени А.В. Топчиева Ран Гидрофильные биологически совместимые адгезивные композиции и их применение
TWI389709B (zh) * 2005-12-01 2013-03-21 Novartis Ag 經皮治療系統
DE102006054731B4 (de) * 2006-11-21 2013-02-28 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Verabreichung des Wirkstoffs Buprenorphin und Verwendung desselben in der Schmerztherapie
CN102089262A (zh) * 2008-04-09 2011-06-08 康瑟特制药公司 3-(2-羟基-5-甲基苯基)-n，n-二异丙基-3-苯丙胺的衍生物及其使用方法
US20090297591A1 (en) * 2008-05-30 2009-12-03 Orient Pharma Co., Ltd. Compositions And Methods For The Transdermal Delivery Of Pharmaceutical Compounds
AU2010204986B2 (en) 2009-01-14 2016-06-02 Corium International, Inc. Transdermal administration of tamsulosin
KR20110001103A (ko) * 2009-06-29 2011-01-06 에스케이케미칼주식회사 보관 안정성이 향상된 톨테로딘 함유 경피 투여 조성물
KR101746204B1 (ko) * 2010-02-18 2017-06-13 에스케이케미칼주식회사 피부 투과가 개선된 톨테로딘의 경피 투여용 조성물
WO2011120084A1 (en) * 2010-03-30 2011-10-06 Phosphagenics Limited Transdermal delivery patch
JP2012051875A (ja) * 2010-08-03 2012-03-15 Hisamitsu Pharmaceut Co Inc 経皮・経粘膜吸収製剤の保存方法及び経皮・経粘膜吸収製剤包装体
JP5642790B2 (ja) * 2010-08-03 2014-12-17 久光製薬株式会社 貼付剤及びその粘着力増強方法
AP4036A (en) 2011-12-12 2017-02-22 Lohmann Therapie Syst Lts Transdermal delivery system comprising buprenorphine
EP2799066B1 (en) * 2011-12-27 2021-01-20 Teikoku Seiyaku Co., Ltd. Tolterodine-containing adhesive patch
JP6559121B2 (ja) 2013-06-04 2019-08-14 エルテーエス ローマン テラピー−ジステーメ アーゲー 経皮送達システム

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4310012A1 (de) * 1993-03-27 1994-09-29 Roehm Gmbh Dermales therapeutisches System aus einer schmelzfähigen Poly(meth)acrylat-Mischung
JP3739806B2 (ja) * 1993-05-26 2006-01-25 埼玉第一製薬株式会社 骨格筋弛緩経皮吸収剤
US5785991A (en) * 1995-06-07 1998-07-28 Alza Corporation Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
US6310103B1 (en) 1996-07-19 2001-10-30 Bridge Pharma, Inc. S(−)-tolterodine in the treatment of urinary and gastrointestinal disorders
DE19653606A1 (de) * 1996-12-20 1998-06-25 Roehm Gmbh Haft- und Bindemittel aus (Meth)acrylatpolymer, organischer Säure und Weichmacher
SE9802864D0 (sv) 1998-08-27 1998-08-27 Pharmacia & Upjohn Ab Transdermally administered tolterodine as antimuscarinic agent for the treatment of overactive bladder
EP1039882B1 (en) * 1998-08-27 2010-11-10 Pfizer Health AB Therapeutic formulation for administering tolterodine with controlled release

Also Published As

Publication number Publication date
NO20015614D0 (no) 2001-11-16
NO20015614L (no) 2001-11-16
ZA200108147B (en) 2002-06-27
EP1178782B1 (de) 2006-08-09
CN1356894A (zh) 2002-07-03
ES2270832T3 (es) 2007-04-16
WO2000069421A2 (de) 2000-11-23
HK1047703A1 (zh) 2003-03-07
AU4921800A (en) 2000-12-05
US6783769B1 (en) 2004-08-31
DE50013305D1 (de) 2006-09-21
EP1178782A2 (de) 2002-02-13
DK1178782T3 (da) 2006-12-11
CA2373629A1 (en) 2000-11-23
ATE335469T1 (de) 2006-09-15
AU772648B2 (en) 2004-05-06
WO2000069421A3 (de) 2001-03-22
JP2002544222A (ja) 2002-12-24
PT1178782E (pt) 2006-12-29
RU2251413C2 (ru) 2005-05-10
MXPA01011536A (es) 2003-09-10
PL352057A1 (en) 2003-07-28
DE19922662C1 (de) 2000-12-28

Similar Documents

Publication Publication Date Title
BR0010618A (pt) Sistema terapêutico transdermal (tts), que contém tolterodina
PT1077688E (pt) Sistema terapeutico transdermico contendo pergolide
DE59608650D1 (de) Hormonpflaster
DK0764020T3 (da) Transdermalt system til indgivelse af lægemiddel
ES2165232T3 (es) Sistema terapeutico transdermico (tts) que contiene oxibutinina.
FI970788A0 (fi) Kasveilla käytettäviksi tarkoitettuja suihkutettavissa olevia, kalvon muodostavia järjestelmiä vaikuttavien aineiden antamiseksi
DE59308413D1 (de) Pflaster zur transdermalen verabreichung von flüchtigen, pharmazeutisch wirksamen, chemisch basischen inhaltsstoffen und verfahren zu seiner herstellung
PT1003477E (pt) Sistema terapeutico transdermico (tts), contendo polimeros de (met)acrilato com grupos amonio para administracao de levonorgestrel
ATE395050T1 (de) Transdermales therapeutisches system für die verabreichung carboxylgruppenhaltiger, nichtsteroidaler antiphlogistika, sowie verfahren zu seiner herstellung
FI971711A (fi) Levobupivakaiinin ja sen analogien kiteyttäminen
BRPI0011135B8 (pt) sistema de ministração terapêutica transdérmica contendo agente neuroléptico
MD937C2 (ro) Sistem terapeutic transdermal pentru aplicarea cutanală a fizostigminei pe piele şi procedeu de obţinere a lui
IT1297139B1 (it) Composizioni per la somministrazione transdermica e dermica di sostanze biologicamente attive
WO2001070224A3 (fr) Pansement a base de rilmenidine et son procede de preparation
MX9707868A (es) La triacetina como incrementador de penetracion transdermica.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A E 9A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 NA RPI2003 DE 26/05/2009.